Cardinal HealthCAHEarnings & Financial Report
Cardinal Health, Inc. is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products.
CAH Q2 2026 Key Financial Metrics
売上高
$65.6B
粗利益
$2.4B
営業利益
$707.0M
純利益
$467.0M
粗利益率
3.7%
営業利益率
1.1%
純利益率
0.7%
前年比成長
19.6%
資金フロー
Cardinal Health Q2 2026 Financial Summary
Cardinal Health reported revenue of $65.6B for Q2 2026, with a net profit of $467.0M (0.7% margin). Cost of goods sold was $63.2B, operating expenses totaled $1.7B.
Key Financial Metrics
| Total Revenue | $65.6B |
|---|---|
| Net Profit | $467.0M |
| Gross Margin | 3.7% |
| Operating Margin | 1.1% |
| Report Period | Q2 2026 |
Cardinal Health Annual Revenue by Year
Cardinal Health annual revenue history includes year-by-year totals (for example, 2025 revenue was $239.4B).
| Year | Annual Revenue |
|---|---|
| 2025 | $239.4B |
| 2024 | $217.4B |
| 2023 | $213.2B |
| 2022 | $190.7B |
損益計算書
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $54.91B | $52.28B | $55.26B | $54.88B | $54.88B | $64.01B | $65.63B | $65.63B |
| 前年比成長 | 8.8% | -4.5% | -3.8% | -0.1% | -0.1% | 22.4% | 18.8% | 19.6% |
貸借対照表
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $45.12B | $43.06B | $47.00B | $49.87B | $53.12B | $55.23B | $58.08B | $58.08B |
| 総負債 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 株主資本 | $-3.21B | $-3.28B | $-2.99B | $-2.95B | $-2.78B | $-2.88B | $-2.88B | $-2.88B |
キャッシュフロー
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| 営業CF | $2.08B | $-1.65B | $-400.0M | $2.92B | $1.53B | $973.0M | $686.0M |
Other Health Care Companies
COR
Cencora
売上高
$85.9B
純利益
$559.6M
HSIC
Henry Schein
売上高
$3.3B
純利益
$101.0M
MCK
McKesson Corporation
売上高
$106.2B
純利益
$1.2B
ABT
Abbott Laboratories
売上高
$11.4B
純利益
$1.6B
ABBV
AbbVie
売上高
$15.8B
純利益
$186.0M
A
Agilent Technologies
売上高
$1.9B
純利益
$434.0M
ALGN
Align Technology
売上高
$995.7M
純利益
$56.8M
AMGN
Amgen
売上高
$9.9B
純利益
$1.3B
BAX
Baxter International
売上高
$3.0B
純利益
$-1.1B
BDX
Becton Dickinson
売上高
$5.3B
純利益
$382.0M